The goal of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a high affinity, full agonist of the 5-HT1A (serotonin) receptor in healthy elderly subjects. The compound may be efficacious in preventing stroke.
Showing the most recent 10 out of 381 publications